| PERIOD ENDING | 31-Mar-09 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 57,107 | 29,136 | 19,139 | | Cost of Revenue | 13,218 | 8,024 | 2,895 | | | Gross Profit | 43,889 | 21,112 | 16,244 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 53,444 | 30,690 | 19,067 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (9,555) | (9,578) | (2,822) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (9,767) | 399 | 211 | | Earnings Before Interest And Taxes | (19,741) | (9,179) | (2,611) | | Interest Expense | 757 | 975 | 851 | | Income Before Tax | (20,498) | (10,155) | (3,462) | | Income Tax Expense | (256) | (2,006) | 515 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (20,242) | (8,149) | (3,977) | | | Non-recurring Events | | Discontinued Operations |
-
| (110) | 208 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (20,242) | (8,259) | (3,770) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($20,242) | ($8,259) | ($3,770) |
|
1.23% Nasdaq 
0.0068 (17.99%) 
Income Statement
